Canonical Transient Receptor Potential Channels Promote Cardiomyocyte Hypertrophy through Activation of Calcineurin Signaling*
暂无分享,去创建一个
E. Olson | T. McKinsey | P. Papst | J. Chapo | M. Bristow | W. Minobe | E. Bush | D. B. Hood
[1] B. Tombal,et al. Calcium store contents control the expression of TRPC1, TRPC3 and TRPV6 proteins in LNCaP prostate cancer cell line. , 2006, Cell calcium.
[2] J. Putney,et al. Mechanism of Inhibition of TRPC Cation Channels by 2-Aminoethoxydiphenylborane , 2005, Molecular Pharmacology.
[3] J. Putney. Physiological mechanisms of TRPC activation , 2005, Pflügers Archiv.
[4] Bernd Nilius,et al. TRP Channels in Disease , 2005, Science's STKE.
[5] J. Soboloff,et al. A Functional Link between Store-operated and TRPC Channels Revealed by the 3,5-Bis(trifluoromethyl)pyrazole Derivative, BTP2* , 2005, Journal of Biological Chemistry.
[6] G. Barritt,et al. TRPs as mechanosensitive channels , 2005, Nature Cell Biology.
[7] A. Kurosky,et al. TRPC1 forms the stretch-activated cation channel in vertebrate cells , 2005, Nature Cell Biology.
[8] B. Harrison,et al. The CRM1 Nuclear Export Receptor Controls Pathological Cardiac Gene Expression , 2004, Molecular and Cellular Biology.
[9] J. Soboloff,et al. Sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA) gene silencing and remodeling of the Ca2+ signaling mechanism in cardiac myocytes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[10] P. Thistlethwaite,et al. Bosentan inhibits transient receptor potential channel expression in pulmonary vascular myocytes. , 2004, American journal of respiratory and critical care medicine.
[11] J. Molkentin,et al. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. , 2004, Biochemical and biophysical research communications.
[12] J. Putney,et al. Obligatory Role of Src Kinase in the Signaling Mechanism for TRPC3 Cation Channels* , 2004, Journal of Biological Chemistry.
[13] I. Fantozzi,et al. Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[14] R. Bassel-Duby,et al. TRPC3 channels confer cellular memory of recent neuromuscular activity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[15] B. DeDecker,et al. Chemical genetics to identify NFAT inhibitors: Potential of targeting calcium mobilization in immunosuppression , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[16] M. Hoth,et al. Potent Inhibition of Ca2+ Release-activated Ca2+ Channels and T-lymphocyte Activation by the Pyrazole Derivative BTP2* , 2004, Journal of Biological Chemistry.
[17] E. Olson,et al. A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[18] H. Kwan,et al. Regulation of canonical transient receptor potential isoform 3 (TRPC3) channel by protein kinase G. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[19] E. Olson,et al. Cardiac hypertrophy: the good, the bad, and the ugly. , 2003, Annual review of physiology.
[20] Rick B. Vega,et al. The role of modulatory calcineurin-interacting proteins in calcineurin signaling. , 2003, Trends in cardiovascular medicine.
[21] Antonio Riccio,et al. mRNA distribution analysis of human TRPC family in CNS and peripheral tissues. , 2002, Brain research. Molecular brain research.
[22] H. Debaix,et al. Involvement of TRPC in the abnormal calcium influx observed in dystrophic (mdx) mouse skeletal muscle fibers , 2002, The Journal of cell biology.
[23] R. Marchase,et al. Capacitative Calcium Entry Contributes to Nuclear Factor of Activated T-cells Nuclear Translocation and Hypertrophy in Cardiomyocytes* , 2002, The Journal of Biological Chemistry.
[24] G. Crabtree,et al. NFAT Signaling Choreographing the Social Lives of Cells , 2002, Cell.
[25] Julie A. Wilkins,et al. Potent Inhibition of NFAT Activation and T Cell Cytokine Production by Novel Low Molecular Weight Pyrazole Compounds* , 2001, The Journal of Biological Chemistry.
[26] Rick B. Vega,et al. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[27] E. Olson,et al. Independent Signals Control Expression of the Calcineurin Inhibitory Proteins MCIP1 and MCIP2 in Striated Muscles , 2000, Circulation research.
[28] E. Olson,et al. Decoding calcium signals involved in cardiac growth and function , 2000, Nature Medicine.
[29] Rick B. Vega,et al. A Protein Encoded within the Down Syndrome Critical Region Is Enriched in Striated Muscles and Inhibits Calcineurin Signaling* , 2000, The Journal of Biological Chemistry.
[30] T. Gudermann,et al. Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol , 1999, Nature.
[31] Jeffrey Robbins,et al. A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.
[32] J. Sadoshima,et al. The cellular and molecular response of cardiac myocytes to mechanical stress. , 1997, Annual review of physiology.
[33] R. Cody,et al. Echocardiographic characterization of left ventricular adaptation in a genetically determined heart failure rat model. , 1995, American heart journal.
[34] D. Levy,et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.